Should McKinsey have disclosed to the FDA that it was helping opioid manufacturers influence drug-safety regulations?
Katie Porter: “Should McKinsey have disclosed to the FDA that it was helping opioid manufacturers influence drug-safety regulations?”
On the recordApril 26, 2022
Source
congress.govEditor's note · Context
Questioning McKinsey's transparency regarding its work with Purdue Pharma and the FDA.
Share
More from Katie Porter
Sep 24, 2024
I urge my colleagues to oppose the underlying bill, and I yield back the balance of my time. The Acting CHAIR. The question is on the amendment offered by the gentleman from New York (Mr. Molinaro). The amendment was agreed to. Amendment…
Dec 9, 2024
Republicans, Democrats, Independents, we are all seeing people use mail-in ballots and they all deserve peace of mind that their ballots got delivered safely and quickly.
Mar 5, 2025
If Vice President Harris were to choose to run, I am certain that that would have a near field-clearing effect on the Democratic side.





